Gossamer Bio Non-Current Deferred Liabilities (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.495 -0.16 (-6.20%) USD | NASDAQ | Jan 14, 13:39

View Non-Current Deferred Liabilities (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	Upgrade
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	Upgrade